Case Study: Building a Scientific Communications Platform and Narrative for a First-in-Class Hematology Treatment

Introduction

Quill Science LLC partnered with a global medical communications agency (agency) to deliver expert medical strategy and scientific storytelling for a top-10 global pharmaceutical client in hematology (client). With imminent initial approvals and opportunities for future label expansion for the account, the agency needed a senior medical director to lead Scientific Communications Platform (SCP) and scientific narrative development for a first-in-class treatment for a rare bleeding disorder.

This collaboration highlights how Chris from Quill Science provided embedded strategic and executional support that delivered clarity, cohesion, and alignment across teams. This foundation supported high-impact post-launch communications and sales training. The agency was able to deliver this strategic and executive value without overextending their full-time staff.

Challenge

Amid an influx of complex deliverables and shifting timelines, the agency faced a key gap: they lacked a dedicated medical lead to steer the SCP and narrative development for a pivotal hematology program. Their pharmaceutical client needed thoughtful, evidence-backed messaging that could scale across functions—from medical affairs to commercial and training.

The agency needed a senior partner who could move fluently between scientific, strategic, and execution layers—without adding internal headcount or overworking their existing staff.

Approach

Strategic Research & Analysis

Chris reviewed client documents, peer-reviewed publications, treatment guidelines, and congress content to:

• Map the evolving therapeutic landscape

• Uncover messaging gaps and hurdles

• Identify key differentiation opportunities around convenience and patient burden

This work informed the backbone of the scientific platform and messaging framework.

Platform & Narrative Development

Working closely with agency teams and the pharma client through weekly touchpoints, Quill Science:

• Created four strategic pillars for the SCP

• Developed a detailed, well-researched, and forward-looking narrative document aligned with the SCP

• Ensured consistency and modularity to accommodate future data releases and label expansions

Expanding the Scope

Near the start of the project, the client wanted to include a workshop initially scoped as an internal sales training tool. Thanks to its success and cross-functional value, it was expanded into a regulatory-approved external Q&A resource.

What began as an internal-facing workshop evolved into a fully vetted, regulatory-approved asset—demonstrating the adaptability and value of strategic content.

Results

Deliverables

• Three comprehensive decks (20–96 slides) developed, reviewed, and approved

• A cohesive, modular SCP and narrative adopted by the pharma client

• A sales training workshop that became a long-term asset

Strategic Wins

• Delivered alignment across scientific and medical messaging

• Enabled the agency to meet tight timelines and exceed expectations

• Supported internal teams and prevented burnout with senior-level coverage

Client Feedback & Long-Term Value

The pharma client was pleased with the narrative and SCP, citing clarity, strategic alignment, and future utility. The agency appreciated Chris’ reliability, strategic thinking, and ability to handle ambiguity—turning a short-term engagement into a six-month successful collaboration.

This project exemplifies how Quill Science supports agencies by providing specialized medical leadership that flexes with business needs—especially in high-stakes, cross-functional workstreams.

Conclusion

For agency partners managing complex accounts, Quill Science offers more than writing—we provide strategic clarity, trusted execution, and true scientific partnership. Whether filling capability gaps or driving large-scale initiatives, we help agencies serve their clients with excellence.